Table 1 Clinical and biochemical characteristics of participants enrolled in the study
Variables | n (%) |
|---|---|
Sex | |
Male | 21 (75.0) |
Female | 7 (25.0) |
Age (years) | |
<60 | 20 (71.4) |
≥60 | 8 (28.6) |
Type of chronic hepatitis | |
Hepatitis B | 24 (85.7) |
Hepatitis C | 4 (14.3) |
Cirrhosis | |
Yes | 26 (92.9) |
No | 2 (7.1) |
AFP(ng/ml) | |
<200 | 22 (78.6) |
≥200 | 6 (21.4) |
Child-Pugh classification | |
A | 24 (85.7) |
B | 4 (14.3) |
ECOG Score | |
0 | 25 (89.3) |
1 | 3 (10.7) |
Tumor diameter (cm) | |
≤2 cm | 14 (50.0) |
>2 cm,≤3 cm | 14 (50.0) |
Use of fiducials in SBRT | |
Yes | 27 (96.4) |
No | 1 (3.6) |
Previous treatments | |
No | 10 (35.7) |
Resection | 2 (7.1) |
TACE | 13 (46.4) |
Resection+TACE | 1 (3.6) |
TACE+RFA | 1 (3.6) |
TACE+PCA | 1 (3.6) |